We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
+11.62%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$409M
AUM Growth
-$44.1M
(-9.7%)
Cap. Flow
-$59.6M
Cap. Flow
% of AUM
-14.56%
Top 10 Holdings %
Top 10 Hldgs %
18.06%
Holding
781
New
279
Increased
97
Reduced
120
Closed
283
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$10.8M |
| 2 |
Microsoft
MSFT
|
+$7.69M |
| 3 |
TSMC
TSM
|
+$6.92M |
| 4 |
AbbVie
ABBV
|
+$6.78M |
| 5 |
NKLA
Nikola Corporation Common Stock
NKLA
|
+$6.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$49.3M |
| 2 |
Biogen
BIIB
|
+$6.69M |
| 3 |
Accenture
ACN
|
+$6.42M |
| 4 |
Target
TGT
|
+$5.14M |
| 5 |
Walt Disney
DIS
|
+$4.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.52% |
| 2 | Consumer Discretionary | 16.31% |
| 3 | Healthcare | 16% |
| 4 | Industrials | 8.7% |
| 5 | Financials | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Neogen
NEOG
$2.56B
| $219K | 0.05% |
+5,600
| New | +$214K |
|
427
Prosperity Bancshares
PB
$8.74B
| $217K | 0.05% |
+4,179
| New | +$229K |
|
428
BioMarin Pharmaceuticals
BMRN
$12.6B
| $215K | 0.05% |
+2,820
| New | +$285K |
|
429
State Street SPDR S&P Regional Banking ETF
KRE
$4.04B
| $214K | 0.05% |
5,995
-57,705
| -91% | -$2.18M |
|
430
HEICO Corp Class A
HEI.A
$35.1B
| $213K | 0.05% |
+2,400
| New | +$203K |
|
|
CODX
431
Co-Diagnostics
CODX
$8.8M
| $212K | 0.05% |
+520
| New | +$267K |
|
432
Flowers Foods
FLO
$1.48B
| $212K | 0.05% |
+8,700
| New | +$204K |
|
433
ArcelorMittal
MT
$56.3B
| $212K | 0.05% |
16,000
-59,137
| -79% | -$713K |
|
434
Upbound Group
UPBD
$1.12B
| $212K | 0.05% |
+7,100
| New | +$210K |
|
435
United Natural Foods
UNFI
$2.86B
| $210K | 0.05% |
+14,100
| New | +$268K |
|
|
JWN
436
DELISTED
Nordstrom
JWN
| $209K | 0.05% |
+17,500
| New | +$262K |
|
437
Sonoco
SON
$5.61B
| $209K | 0.05% |
+4,100
| New | +$217K |
|
438
Scotiabank
BNS
$113B
| $208K | 0.05% |
5,000
-23,201
| -82% | -$974K |
|
439
Sturm, Ruger & Co
RGR
$603M
| $208K | 0.05% |
+3,398
| New | +$251K |
|
440
ITT
ITT
$18.6B
| $207K | 0.05% |
3,500
-11,318
| -76% | -$686K |
|
441
Axalta
AXTA
$7.85B
| $201K | 0.05% |
+9,050
| New | +$210K |
|
442
Sally Beauty Holdings
SBH
$1.54B
| $197K | 0.05% |
+22,652
| New | +$273K |
|
443
Adient
ADNT
$1.45B
| $194K | 0.05% |
11,200
-15,700
| -58% | -$274K |
|
|
LX
444
LexinFintech Holdings
LX
$191M
| $190K | 0.05% |
+27,700
| New | +$241K |
|
|
PRMW
445
DELISTED
Primo Water Corporation
PRMW
| $190K | 0.05% |
+13,369
| New | +$189K |
|
|
OPLN
446
Openlane
OPLN
$4.33B
| $186K | 0.05% |
+12,900
| New | +$202K |
|
447
e.l.f. Beauty
ELF
$6.26B
| $185K | 0.05% |
10,053
-4,500
| -31% | -$85.2K |
|
|
ASAP
448
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
| $183K | 0.04% |
+2,840
| New | +$236K |
|
|
FIT
449
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $183K | 0.04% |
+26,300
| New | +$171K |
|
450
Yext
YEXT
$678M
| $179K | 0.04% |
+11,800
| New | +$199K |
|
Similar funds
MCM
MFG
AFW
ADBIC
HSM
FWM
PIA
CCP
Bayesian Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, Bayesian Capital Management held 781 positions worth $409M, down 9.7% from $453M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bayesian Capital Management withdrew a net $59.6M in Q3 2020, closing 283 positions and reducing 120 holdings. Its most notable exit was Biogen, an estimated $6.69M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Bayesian Capital Management opened a new position in Apple worth $11.5M.
- Bayesian Capital Management's largest Q3 2020 buy was Apple: 99,200 shares worth $11.5M.
- Bayesian Capital Management added most to Microsoft in Q3 2020, an estimated $7.69M increase.
- Bayesian Capital Management's biggest Q3 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $49.3M.
- Bayesian Capital Management fully exited Biogen in Q3 2020, selling an estimated $6.69M.
- Bayesian Capital Management's ten largest holdings make up 18% of its $409M portfolio in Q3 2020.
- Bayesian Capital Management opened 279 new positions and closed 283 in Q3 2020.
- Bayesian Capital Management's portfolio value fell 9.7% quarter-over-quarter to $409M.
Based on Bayesian Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.